Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes

Increased plasma level of soluble urokinase-type plasminogen activator receptor (suPAR) was associated recently with focal segmental glomerulosclerosis (FSGS). In addition, different clinical studies observed increased concentration of suPAR in various glomerular diseases and in other human patholog...

Descripción completa

Detalles Bibliográficos
Autores principales: Alfano, Massimo, Cinque, Paola, Giusti, Guido, Proietti, Silvia, Nebuloni, Manuela, Danese, Silvio, D’Alessio, Silvia, Genua, Marco, Portale, Federica, Lo Porto, Manuela, Singhal, Pravin C., Rastaldi, Maria Pia, Saleem, Moin A., Mavilio, Domenico, Mikulak, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585377/
https://www.ncbi.nlm.nih.gov/pubmed/26380915
http://dx.doi.org/10.1038/srep13647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585377/
https://www.ncbi.nlm.nih.gov/pubmed/26380915
http://dx.doi.org/10.1038/srep13647

Ejemplares similares